Study to evaluate the optimal dose of ⁶⁸ Ga-OPS202 as a PET imaging agent in patients with GEP-NETs

Study to evaluate the optimal dose of ⁶⁸ Ga-OPS202 as a PET imaging agent in patients with GEP-NETs

Gender and age-related changes of thigh muscle fat infiltration in subjects of the OAI MRI cohort without radiographic osteoarthritis